UniProt ID | DCTN4_HUMAN | |
---|---|---|
UniProt AC | Q9UJW0 | |
Protein Name | Dynactin subunit 4 | |
Gene Name | DCTN4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 460 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . In skeletal muscles, demonstrates a punctate distribution along costameres (By similarity). Has a punctate cytoplasmic distribution as well as centrosomal | |
Protein Description | Could have a dual role in dynein targeting and in ACTR1A/Arp1 subunit of dynactin pointed-end capping. Could be involved in ACTR1A pointed-end binding and in additional roles in linking dynein and dynactin to the cortical cytoskeleton.. | |
Protein Sequence | MASLLQSDRVLYLVQGEKKVRAPLSQLYFCRYCSELRSLECVSHEVDSHYCPSCLENMPSAEAKLKKNRCANCFDCPGCMHTLSTRATSISTQLPDDPAKTTMKKAYYLACGFCRWTSRDVGMADKSVASGGWQEPENPHTQRMNKLIEYYQQLAQKEKVERDRKKLARRRNYMPLAFSDKYGLGTRLQRPRAGASISTLAGLSLKEGEDQKEIKIEPAQAVDEVEPLPEDYYTRPVNLTEVTTLQQRLLQPDFQPVCASQLYPRHKHLLIKRSLRCRKCEHNLSKPEFNPTSIKFKIQLVAVNYIPEVRIMSIPNLRYMKESQVLLTLTNPVENLTHVTLFECEEGDPDDINSTAKVVVPPKELVLAGKDAAAEYDELAEPQDFQDDPDIIAFRKANKVGIFIKVTPQREEGEVTVCFKMKHDFKNLAAPIRPIEESDQGTEVIWLTQHVELSLGPLLP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASLLQSDR ------CCHHHCCCE | 14.64 | 22223895 | |
9 | Methylation | ASLLQSDRVLYLVQG CHHHCCCEEEEEECC | 26.11 | - | |
18 | Ubiquitination | LYLVQGEKKVRAPLS EEEECCCHHCCCCHH | 64.49 | 21890473 | |
19 | Ubiquitination | YLVQGEKKVRAPLSQ EEECCCHHCCCCHHH | 32.43 | - | |
25 | Phosphorylation | KKVRAPLSQLYFCRY HHCCCCHHHHHHHHH | 19.65 | 26074081 | |
28 | Phosphorylation | RAPLSQLYFCRYCSE CCCHHHHHHHHHHHH | 7.93 | 26074081 | |
32 | Phosphorylation | SQLYFCRYCSELRSL HHHHHHHHHHHHCCC | 11.08 | 26074081 | |
34 | Phosphorylation | LYFCRYCSELRSLEC HHHHHHHHHHCCCEE | 30.63 | 26074081 | |
60 | Phosphorylation | SCLENMPSAEAKLKK HHHHHCCHHHHHHHC | 28.15 | 30243723 | |
69 (in isoform 2) | Ubiquitination | - | 29.79 | - | |
84 | Phosphorylation | PGCMHTLSTRATSIS CCHHHHCCCCCCCHH | 19.59 | 24719451 | |
85 | Phosphorylation | GCMHTLSTRATSIST CHHHHCCCCCCCHHH | 27.69 | 27080861 | |
88 | Phosphorylation | HTLSTRATSISTQLP HHCCCCCCCHHHCCC | 24.25 | 28857561 | |
89 | Phosphorylation | TLSTRATSISTQLPD HCCCCCCCHHHCCCC | 17.35 | 28857561 | |
89 (in isoform 2) | Ubiquitination | - | 17.35 | - | |
91 | Phosphorylation | STRATSISTQLPDDP CCCCCCHHHCCCCCH | 15.18 | 27251275 | |
100 (in isoform 2) | Ubiquitination | - | 50.33 | - | |
101 | Phosphorylation | LPDDPAKTTMKKAYY CCCCHHHHHHHHHHH | 33.94 | - | |
102 | Phosphorylation | PDDPAKTTMKKAYYL CCCHHHHHHHHHHHH | 26.70 | 28555341 | |
105 | Malonylation | PAKTTMKKAYYLACG HHHHHHHHHHHHHHC | 30.69 | 26320211 | |
105 | Acetylation | PAKTTMKKAYYLACG HHHHHHHHHHHHHHC | 30.69 | 26051181 | |
107 | Phosphorylation | KTTMKKAYYLACGFC HHHHHHHHHHHHCCC | 14.11 | 29496907 | |
108 | Phosphorylation | TTMKKAYYLACGFCR HHHHHHHHHHHCCCC | 7.84 | 29496907 | |
124 (in isoform 2) | Ubiquitination | - | 18.36 | - | |
126 | Ubiquitination | RDVGMADKSVASGGW CCCCCCCCCHHCCCC | 36.97 | 21890473 | |
127 | Phosphorylation | DVGMADKSVASGGWQ CCCCCCCCHHCCCCC | 24.38 | 21406692 | |
130 | Phosphorylation | MADKSVASGGWQEPE CCCCCHHCCCCCCCC | 35.37 | 21406692 | |
141 | Phosphorylation | QEPENPHTQRMNKLI CCCCCHHHHHHHHHH | 21.08 | 21406692 | |
146 | Ubiquitination | PHTQRMNKLIEYYQQ HHHHHHHHHHHHHHH | 41.31 | 21890473 | |
146 | Sumoylation | PHTQRMNKLIEYYQQ HHHHHHHHHHHHHHH | 41.31 | - | |
146 | Sumoylation | PHTQRMNKLIEYYQQ HHHHHHHHHHHHHHH | 41.31 | - | |
146 | Ubiquitination | PHTQRMNKLIEYYQQ HHHHHHHHHHHHHHH | 41.31 | 21890473 | |
149 (in isoform 2) | Ubiquitination | - | 48.93 | - | |
150 | Phosphorylation | RMNKLIEYYQQLAQK HHHHHHHHHHHHHHH | 10.28 | 27642862 | |
151 | Phosphorylation | MNKLIEYYQQLAQKE HHHHHHHHHHHHHHH | 4.13 | 27642862 | |
157 | Ubiquitination | YYQQLAQKEKVERDR HHHHHHHHHHHHHHH | 54.62 | 21890473 | |
159 | Ubiquitination | QQLAQKEKVERDRKK HHHHHHHHHHHHHHH | 57.33 | - | |
173 | Phosphorylation | KLARRRNYMPLAFSD HHHHHHCCCCCHHHC | 9.78 | 21945579 | |
179 | Phosphorylation | NYMPLAFSDKYGLGT CCCCCHHHCCCCCCC | 27.82 | 21945579 | |
181 | Ubiquitination | MPLAFSDKYGLGTRL CCCHHHCCCCCCCCC | 39.77 | 21890473 | |
181 | Ubiquitination | MPLAFSDKYGLGTRL CCCHHHCCCCCCCCC | 39.77 | 21890473 | |
182 | Phosphorylation | PLAFSDKYGLGTRLQ CCHHHCCCCCCCCCC | 23.67 | - | |
196 | Phosphorylation | QRPRAGASISTLAGL CCCCCCCCHHHHHCC | 19.02 | 25693802 | |
198 | Phosphorylation | PRAGASISTLAGLSL CCCCCCHHHHHCCCC | 18.18 | 29978859 | |
199 | Phosphorylation | RAGASISTLAGLSLK CCCCCHHHHHCCCCC | 20.96 | 28060719 | |
203 | Phosphorylation | SISTLAGLSLKEGED CHHHHHCCCCCCCCC | 4.51 | 24719451 | |
204 | Phosphorylation | ISTLAGLSLKEGEDQ HHHHHCCCCCCCCCC | 36.16 | 28060719 | |
206 | Phosphorylation | TLAGLSLKEGEDQKE HHHCCCCCCCCCCCE | 61.37 | 27251275 | |
206 | Ubiquitination | TLAGLSLKEGEDQKE HHHCCCCCCCCCCCE | 61.37 | 21890473 | |
206 | Acetylation | TLAGLSLKEGEDQKE HHHCCCCCCCCCCCE | 61.37 | 18528655 | |
212 | Ubiquitination | LKEGEDQKEIKIEPA CCCCCCCCEEEEECC | 73.97 | 21890473 | |
215 | Sumoylation | GEDQKEIKIEPAQAV CCCCCEEEEECCCCC | 41.95 | 28112733 | |
215 | Ubiquitination | GEDQKEIKIEPAQAV CCCCCEEEEECCCCC | 41.95 | 21890473 | |
232 | Phosphorylation | VEPLPEDYYTRPVNL CCCCCCCCCCCCCCH | 12.69 | 22210691 | |
233 | Phosphorylation | EPLPEDYYTRPVNLT CCCCCCCCCCCCCHH | 14.48 | 22210691 | |
234 | Phosphorylation | PLPEDYYTRPVNLTE CCCCCCCCCCCCHHH | 23.44 | 22210691 | |
267 | Ubiquitination | SQLYPRHKHLLIKRS HHCCHHHHHHHHHHH | 36.91 | - | |
274 | Phosphorylation | KHLLIKRSLRCRKCE HHHHHHHHHHHCCCC | 18.37 | - | |
279 | Ubiquitination | KRSLRCRKCEHNLSK HHHHHHCCCCCCCCC | 47.83 | - | |
286 | Ubiquitination | KCEHNLSKPEFNPTS CCCCCCCCCCCCCCC | 52.30 | - | |
295 | Ubiquitination | EFNPTSIKFKIQLVA CCCCCCCEEEEEEEE | 40.13 | - | |
313 (in isoform 2) | Ubiquitination | - | 32.30 | - | |
370 | Ubiquitination | KELVLAGKDAAAEYD HHHEECCCCHHHHCH | 38.29 | 21890473 | |
376 | Phosphorylation | GKDAAAEYDELAEPQ CCCHHHHCHHHCCCC | 15.25 | 28796482 | |
407 | Phosphorylation | VGIFIKVTPQREEGE EEEEEEEECCCCCCE | 14.54 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DCTN4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DCTN4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DCTN4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ACTZ_HUMAN | ACTR1A | physical | 10671518 | |
ARP10_HUMAN | ACTR10 | physical | 22863883 | |
ACTZ_HUMAN | ACTR1A | physical | 22863883 | |
ACTY_HUMAN | ACTR1B | physical | 22863883 | |
DCTN2_HUMAN | DCTN2 | physical | 22863883 | |
SEH1_HUMAN | SEH1L | physical | 22863883 | |
ACTZ_HUMAN | ACTR1A | physical | 26344197 | |
ACTY_HUMAN | ACTR1B | physical | 26344197 | |
CAZA1_HUMAN | CAPZA1 | physical | 26344197 | |
CAZA2_HUMAN | CAPZA2 | physical | 26344197 | |
CAPZB_HUMAN | CAPZB | physical | 26344197 | |
DCTN1_HUMAN | DCTN1 | physical | 26344197 | |
DCTN2_HUMAN | DCTN2 | physical | 26344197 | |
DCTN5_HUMAN | DCTN5 | physical | 26344197 | |
DCTN6_HUMAN | DCTN6 | physical | 26344197 | |
IF4G1_HUMAN | EIF4G1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM 1), AND MASSSPECTROMETRY. |